The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Higher lipoprotein(a) levels are associated with continuously increasing risk of recurrent atherosclerotic cardiovascular disease events, regardless of sex and race/ethnicity.

Predicting Risk of Cardiovascular Disease Events (PREVENT) risk score accurately identifies individuals with coronary artery calcium.

There is minimal available, easy-to-access information on suicide prevention in older adults, suggesting systemic implicit biases.